Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Kleideiter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Screening of telomerase inhibitorsElke Kleideiter, Kamilla Piotrowska, Ulrich Klotz
Clinical Pharmacokinetics|June 18, 2017
Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class AnalgesicElke Kleideiter, Chiara Piana, Shaonan Wang, et al.
Clinical Pharmacokinetics|June 28, 2018
Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class AnalgesicElke Kleideiter, Chiara Piana, Shaonan Wang, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 9, 2020
Evaluation of the effect of naltrexone coadministration on the pharmacokinetics of oxycodone in a randomized phase 1 clinical trial
Elke Kleideiter, Stefan Buller, Robert Nemeth, et al.
Experimental and Molecular Pathology|October 1, 2003
Tumorigenic conversion of endothelial cellsVera Krump-Konvalinkova, Elke Kleideiter, Ulrike Friedrich, et al.
Pediatric Research|August 9, 2003
Telomerase activity in cell lines of pediatric soft tissue sarcomasElke Kleideiter, Matthias Schwab, Ulrike Friedrich, et al.
Journal of Clinical Psychopharmacology|December 12, 2018
Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled StudyKarin Göhler, Marta Sokolowska, Kerri A Schoedel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 20, 2005
Optimization of the TRAP assay to evaluate specificity of telomerase inhibitorsKamilla Piotrowska, Elke Kleideiter, Thomas E Mürdter, et al.
Digestive Diseases and Sciences|January 13, 2004
Telomerase activity in chronic inflammatory bowel diseaseElke Kleideiter, Ulrike Friedrich, Alexandra Möhring, et al.
Journal of Pharmaceutical Sciences|September 23, 2008
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNAJulia Beisner, Meng Dong, Sebastian Taetz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Screening of telomerase inhibitorsElke Kleideiter, Kamilla Piotrowska, Ulrich Klotz
Clinical Pharmacokinetics|June 18, 2017
Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class AnalgesicElke Kleideiter, Chiara Piana, Shaonan Wang, et al.
Clinical Pharmacokinetics|June 28, 2018
Correction to: Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class AnalgesicElke Kleideiter, Chiara Piana, Shaonan Wang, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 9, 2020
Evaluation of the effect of naltrexone coadministration on the pharmacokinetics of oxycodone in a randomized phase 1 clinical trial
Elke Kleideiter, Stefan Buller, Robert Nemeth, et al.
Experimental and Molecular Pathology|October 1, 2003
Tumorigenic conversion of endothelial cellsVera Krump-Konvalinkova, Elke Kleideiter, Ulrike Friedrich, et al.
Pediatric Research|August 9, 2003
Telomerase activity in cell lines of pediatric soft tissue sarcomasElke Kleideiter, Matthias Schwab, Ulrike Friedrich, et al.
Journal of Clinical Psychopharmacology|December 12, 2018
Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled StudyKarin Göhler, Marta Sokolowska, Kerri A Schoedel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 20, 2005
Optimization of the TRAP assay to evaluate specificity of telomerase inhibitorsKamilla Piotrowska, Elke Kleideiter, Thomas E Mürdter, et al.
Digestive Diseases and Sciences|January 13, 2004
Telomerase activity in chronic inflammatory bowel diseaseElke Kleideiter, Ulrike Friedrich, Alexandra Möhring, et al.
Journal of Pharmaceutical Sciences|September 23, 2008
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNAJulia Beisner, Meng Dong, Sebastian Taetz, et al.
Pageof 1